Champions Oncology, Inc. (FRA:2I3)

Champions Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	69	86	62	60	99	119
Market Cap Growth	-51.62%	40.09%	2.01%	-38.66%	-17.49%	42.38%
Enterprise Value	66	89	65	58	99	119
Last Close Price	4.98	6.40	4.50	4.42	7.40	9.15
PE Ratio	31.76	20.85	-	-	189.51	396.90
PS Ratio	1.35	1.72	1.32	1.24	2.12	3.50
PB Ratio	18.70	25.98	-34.65	14.39	11.42	19.34
P/TBV Ratio	20.63	28.51	-	15.51	11.85	20.26
P/FCF Ratio	14.03	14.01	-	60.64	25.25	-
P/OCF Ratio	12.71	13.27	-	16.80	15.99	-
EV/Sales Ratio	1.33	1.78	1.38	1.19	2.13	3.48
EV/EBITDA Ratio	13.48	15.65	-	-	46.90	92.05
EV/EBIT Ratio	31.58	20.94	-	-	172.63	389.82
EV/FCF Ratio	13.50	14.51	-	58.12	25.48	-
Debt / Equity Ratio	1.28	1.68	-3.90	1.86	1.04	1.29
Debt / EBITDA Ratio	0.94	0.76	-	-	2.29	3.37
Debt / FCF Ratio	0.96	0.90	-	7.82	2.30	-
Net Debt / Equity Ratio	-0.73	-0.92	-2.53	-0.33	0.05	0.66
Net Debt / EBITDA Ratio	-0.78	-0.53	-0.95	0.54	0.21	3.17
Net Debt / FCF Ratio	-0.55	-0.49	-0.69	-1.38	0.11	-0.99
Asset Turnover	2.11	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.91	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.96	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	98.94%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	5.56%	10.36%	-14.31%	-7.98%	1.21%	0.95%
Return on Invested Capital (ROIC)	1811.03%	300.90%	-229.71%	-70.22%	5.21%	4.70%
Return on Capital Employed (ROCE)	30.70%	57.10%	-150.80%	-35.40%	3.40%	2.20%
Earnings Yield	3.15%	4.80%	-11.04%	-8.00%	0.53%	0.25%
FCF Yield	7.13%	7.14%	-10.58%	1.65%	3.96%	-3.45%
Buyback Yield / Dilution	-4.06%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.